This site is intended for healthcare professionals only
Amardip Virdi bought the “entire stock” of Ozempic at a pharmacy where he was working during a national shortage to supply it to private weight loss customers, the GPhC’s investigating committee has found.
A pharmacist has this month (September 5) been served with a warning by the General Pharmaceutical Council’s (GPhC) investigating committee after he bought “the entire stock” of Ozempic at a Tesco pharmacy for his private weight loss customers.
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
The pharmacy regulator has issued a warning to a pharmacist who “engaged in unsolicited services from an unknown broker” for “financial gain”.
In the first month of its updated guidance, the pharmacy regulator has already referred three individuals for fitness-to-practise (FtP) investigations for concerns around weight management drugs, C+D has learned.
The pharmacy regulator has revealed that it has “opened an investigation into the concerns raised” by a coroner after a man who was unable to get his prescription died.
1Alliance Healthcare has revealed “plans to close” two Midlands service centres and proposed cuts at another, putting hundreds of jobs at risk.
4Prime Minister Keir Starmer has announced that NHS England will be abolished to bring the management of the NHS “back into democratic control”.
